Pavic M, Sève P, Malcus C, Sarrot-Reynault F, Peyramond D, Debourdeau P, Andriamanantena D, Bouhour D, Philippe N, Rousset H, Broussolle C
Service de médecine interne, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon, France.
Rev Med Interne. 2005 Feb;26(2):95-102. doi: 10.1016/j.revmed.2004.11.001.
Autoimmune manifestations (AIM) are associated to common variable immunodeficiency (CVI) in about 20 to 25% of the cases. This study presents the clinical, biological characteristics and the evolution of nine patients developing CVI and AIM. A peripheral B-cell compartment analysis has been performed in seven cases.
This multicenter retrospective study analyses nine patients, six men and three women, within a population of 32 CVI.
The mean age was 27 years at the time of diagnosis of AIM and 30 years at the time of diagnosis of CVI. The diagnosis of AIM preceded the diagnosis of CVI in five cases. Thirteen AIM of different types were observed: autoimmune hemolytic anemia (AHA, 3), immune thrombocytopenic purpura (ITP, 2), Evan's syndrome (2), primary biliary cirrhosis (1), rheumatoid arthritis (1), alopecia totalis (1), myasthenia gravis (1). The peripheral B-cell compartment was investigated in seven patients: five patients with autoimmune cytopenia presented with a diminution of memory B cells (CD27+IgD-) and immature B cells (CD21-) levels; the patient with primary biliary cirrhosis and myasthenia gravis had only a diminution of memory B cells level; the last patient with ITP presented with a normal level of memory B cells. Five among the seven patients with autoimmune cytopenia required a specific treatment using corticosteroids, high dosages of intravenous immunoglobulin, then splenectomy after failure of the medical management, with severe infectious complications in one case.
The association of AIM and CVI is not fortuitous. The most common AIM is autoimmune cytopenia. The peripheral B-cell compartment analyses show that a majority of patients have a defect in memory B-cells. Treatment regimens are not standardized and splenectomy increases the risk of infectious complications.
自身免疫表现(AIM)在约20%至25%的常见可变免疫缺陷(CVI)病例中出现。本研究展示了9例发生CVI和AIM患者的临床、生物学特征及病情演变。对其中7例患者进行了外周B细胞亚群分析。
这项多中心回顾性研究分析了32例CVI患者群体中的9例患者,其中6例男性,3例女性。
AIM诊断时的平均年龄为27岁,CVI诊断时的平均年龄为30岁。5例患者AIM诊断先于CVI诊断。观察到13种不同类型的AIM:自身免疫性溶血性贫血(AHA,3例)、免疫性血小板减少性紫癜(ITP,2例)、伊文氏综合征(2例)、原发性胆汁性肝硬化(1例)、类风湿关节炎(1例)、全秃(1例)、重症肌无力(1例)。对7例患者进行了外周B细胞亚群研究:5例自身免疫性血细胞减少患者的记忆B细胞(CD27+IgD-)和未成熟B细胞(CD21-)水平降低;原发性胆汁性肝硬化和重症肌无力患者仅记忆B细胞水平降低;最后1例ITP患者的记忆B细胞水平正常。7例自身免疫性血细胞减少患者中有5例需要使用皮质类固醇、大剂量静脉注射免疫球蛋白进行特异性治疗,药物治疗失败后行脾切除术,其中1例出现严重感染并发症。
AIM与CVI的关联并非偶然。最常见的AIM是自身免疫性血细胞减少。外周B细胞亚群分析显示,大多数患者存在记忆B细胞缺陷。治疗方案不规范,脾切除术增加了感染并发症的风险。